Brighton Collaboration Case Definitions are designed to facilitate evaluation of adverse events following immunization (AEFI) and adverse events of special interest (AESI) for novel pathogens.
(49 - 60 of 73)
Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following[...]
The need for developing a case definition for narcolepsy as an adverse event following immunization (AEFI): 1.1.1. General Introduction Narcolepsy is a sleep[...]
Need for developing case definitions and guidelines for viscerotropic disease as an adverse event following immunization: Viscerotropic disease (VTD) is defined as acute[...]
Need for developing a case definition and guidelines for immunization site pain as an adverse event following immunization [AEFI]: Pain is defined as[...]
The need for developing a case definition and guidelines for a local reaction at or near the injection site, methods for the development[...]
Rash was the third most common adverse events reported by the U.S. Vaccine Adverse Event Reporting System (VAERS) during 1991–2001 (occurring in 11%[...]
Need for developing case definitions and guidelines for adverse events following exposure to vaccinia virus: Following a declaration by The World Health Assembly[...]
Need for developing case definitions and guidelines for abscess at injection site as an adverse events following immunization: An abscess at an injection[...]
Adverse events following exposure to vaccinia virus: Following a declaration by The World Health Assembly in 1980 on the worldwide eradication of smallpox[...]
Need for developing case definitions and guidelines for cellulitis at injection site as an adverse events following immunization Cellulitis is an inflammatory condition[...]
Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030
© Brighton Collaboration 2023. All rights reserved.